Safety Shot, Inc. (SHOT)

Safety Shot, Inc. (SHOT) Consumer Business Overview

Safety Shot, Inc. operates in the functional beverage and wellness sector, specializing in the Safety Shot Beverage for blood alcohol reduction and a diverse pipeline including dermatological and sexual wellness solutions. The company leverages a multi-channel distribution strategy for its proprietary over-the-counter products.

What Is the Investment Thesis for SHOT?

Safety Shot, Inc. presents an investment profile centered on its pioneering efforts in the functional beverage and wellness sector, particularly with its Safety Shot Beverage designed for blood alcohol reduction. A key value driver is the potential first-mover advantage within this emerging beverage category, coupled with a diverse pipeline of proprietary therapeutic solutions for dermatological, hair loss, and women's sexual wellness markets. The company's gross margin of 53.5% indicates a healthy product-level profitability, which could support future scaling. Growth catalysts include the successful expansion of distribution channels for the Safety Shot Beverage, achieving broader market acceptance, and the commercialization of its varied therapeutic product pipeline, such as Photocil or JW-700. However, the company faces significant risks, including a limited operating history and a substantial negative profit margin of -786.5%, highlighting current unprofitability. Challenges in scaling production, securing widespread distribution, and navigating the highly competitive beverage and over-the-counter markets will be critical to its long-term viability and ability to convert its innovative products into sustainable revenue streams. The small market capitalization of $47.41M and a beta of 1.64 suggest higher volatility and inherent risks associated with early-stage growth companies.

Based on FMP financials and quantitative analysis

SHOT Key Highlights

• Market Capitalization: $0.05 billion, reflecting a micro-cap valuation within the consumer defensive sector.
• Gross Margin: 53.5%, indicating a strong margin on products sold before operating expenses.
• Profit Margin: -786.5%, highlighting significant current unprofitability and substantial operational losses.
• Beta: 1.64, suggesting the stock's price tends to be more volatile than the overall market.
• Strategic Focus: Development and commercialization of a diverse portfolio including functional beverages and proprietary over-the-counter therapeutic solutions.

Who Are SHOT's Competitors?

SHOT is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are SHOT's Key Strengths?

• Proprietary product pipeline, including the unique Safety Shot Beverage and diverse therapeutic solutions.
• Potential first-mover advantage in the specific 'blood alcohol reduction' functional beverage category.
• Multi-channel distribution strategy utilizing wholesale, retail, and e-commerce platforms.
• High gross margin of 53.5%, indicating strong product-level profitability.

What Are SHOT's Weaknesses?

• Limited operating history since rebranding in September 2023, and a small employee base of 8.
• Significant negative profit margin of -786.5%, highlighting substantial current unprofitability.
• Challenges inherent in establishing a new product category and gaining widespread consumer acceptance.
• Reliance on successful commercialization of multiple products across diverse health and wellness categories.

What Could Drive SHOT Stock Higher?

• Expansion of Safety Shot Beverage distribution into new national retail chains and increased availability in conventional retail outlets, expected to broaden market reach and sales volume.
• Commercial launch and market introduction of Photocil, the company's dermatological solution for conditions like psoriasis and vitiligo, diversifying its product portfolio and revenue streams.
• Significant progress in the development and potential clinical trials for pipeline products such as JW-700 (hair loss treatment) or JW-500 (women's sexual wellness support), indicating future commercialization potential.
• Scaling of production capabilities for the Safety Shot Beverage to meet anticipated increases in demand and support wider distribution efforts.
• Execution of targeted marketing campaigns designed to enhance consumer awareness and drive adoption of the Safety Shot Beverage in a competitive functional beverage market.

What Are the Key Risks for SHOT?

• Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
• Significant unprofitability, as evidenced by a -786.5% profit margin, poses a substantial risk to sustained operations and requires effective capital management to fund ongoing development and commercialization efforts.
• Challenges in achieving widespread market acceptance and scaling distribution for the Safety Shot Beverage within a highly competitive consumer market, potentially hindering revenue growth and profitability.
• Regulatory hurdles or consumer skepticism regarding the efficacy and safety claims of its proprietary products, particularly in the health and wellness sector, which could impact market entry and adoption.
• Limited operating history and a small employee base of 8 may strain resources for simultaneous product development, marketing, and commercialization across multiple diverse product categories.
• Intense competition from established players in both the functional beverage market and the over-the-counter therapeutic product segments, which possess greater resources and market presence.

What Are the Growth Opportunities for SHOT?

• Expansion of Safety Shot Beverage Distribution: The market for functional beverages continues to expand, driven by health-conscious consumers. Safety Shot, Inc. has a significant opportunity to scale the distribution of its flagship beverage beyond current channels. By securing partnerships with larger national retail chains, expanding its presence in convenience stores, and leveraging strategic e-commerce initiatives, the company can tap into a broader consumer base. This expansion is critical to capitalize on the potential first-mover advantage in the post-alcohol recovery beverage segment, which is estimated to be a rapidly growing niche within the broader wellness market over the next 3-5 years.
• Commercialization of Dermatological Solutions (Photocil): Safety Shot, Inc.'s pipeline includes Photocil, a therapeutic solution targeting dermatological conditions such as psoriasis and vitiligo. The global market for dermatological treatments is substantial, projected to reach over $50 billion by 2028. Successfully bringing Photocil to market, following rigorous testing and regulatory approvals, represents a significant growth avenue. This would diversify the company's revenue streams beyond beverages and allow it to penetrate the specialized pharmaceutical and over-the-counter dermatology sectors, offering a long-term growth trajectory over the next 5-7 years.
• Development and Launch of Hair Loss Treatment (JW-700): The global hair loss treatment market is a multi-billion dollar industry, driven by widespread consumer demand for effective solutions. Safety Shot, Inc.'s JW-700, aimed at treating hair loss, positions the company to capture a share of this lucrative market. Successful development, clinical validation, and subsequent commercial launch of JW-700 could provide a substantial new revenue stream. This opportunity involves a multi-year development and regulatory pathway, with significant market potential upon successful product introduction within the next 4-6 years.
• Entry into Women's Sexual Wellness Market (JW-500): The women's sexual wellness market is an increasingly recognized and growing segment, driven by evolving societal attitudes and a focus on holistic health. Safety Shot, Inc.'s JW-500, formulated to support women's sexual wellness, positions the company to address an underserved consumer need. Successfully developing and marketing this product could unlock a significant market opportunity, diversifying the company's portfolio into a high-growth, specialized health category. This represents a medium-to-long term growth driver, potentially impacting revenues within the next 3-5 years.
• Innovation in Niche Protection Products (NoStingz): The NoStingz sunscreen, offering protection against jellyfish stings, represents a unique product in the outdoor and travel consumer market. While potentially a smaller market segment compared to its other offerings, this product provides a distinct competitive advantage in a niche. Expanding distribution to coastal regions, resorts, and travel-related retailers could capture a specific consumer demographic. This specialized product could contribute to revenue diversification and brand recognition in unique outdoor protection categories, with potential for incremental growth over the next 2-4 years.

What Opportunities Does SHOT Have?

• Growing global market for functional beverages and increasing consumer demand for wellness-focused products.
• Expansion into diverse health and wellness niches with its pipeline products (dermatology, hair loss, sexual wellness).
• Securing additional distribution channels and partnerships to increase market penetration for the Safety Shot Beverage.
• Leveraging e-commerce platforms to directly reach consumers and build brand loyalty.

What Threats Does SHOT Face?

• Intense competition from established players in both the functional beverage and over-the-counter therapeutic markets.
• Potential for regulatory scrutiny and challenges in substantiating health claims for new products.
• Consumer skepticism or slow adoption rates for novel products, particularly in health-related categories.
• Significant capital requirements for scaling production, marketing, and continued research and development amidst unprofitability.

What Are SHOT's Competitive Advantages?

• Proprietary intellectual property underpinning its diverse product pipeline, including the Safety Shot Beverage and therapeutic solutions.
• Potential first-mover advantage in the specific functional beverage category targeting blood alcohol reduction.
• Multi-channel distribution strategy encompassing wholesale, retail, and e-commerce, enhancing market penetration.
• Focus on niche wellness and functional health solutions, addressing specific consumer needs not broadly covered by mainstream products.

What Does SHOT Do?

Safety Shot, Inc., originally incorporated in 2018 as Jupiter Wellness, Inc., underwent a significant rebranding in September 2023 to its current name. Headquartered in Jupiter, Florida, the company is strategically positioned within the dynamic wellness and functional beverage sector. Its core business revolves around the research, development, and commercialization of both over-the-counter consumer products and proprietary intellectual property designed to address various health and wellness needs. The flagship product, the Safety Shot Beverage, is a non-prescription drink specifically engineered to expedite the reduction of blood alcohol content, positioning the company as a potential first-mover in a novel segment of post-alcohol recovery solutions. Beyond this primary offering, Safety Shot, Inc. is actively cultivating a comprehensive and varied portfolio of therapeutic solutions. This pipeline includes Photocil, a product under development aimed at addressing dermatological conditions such as psoriasis and vitiligo, demonstrating the company's ambition to tackle prevalent skin health issues. Additionally, the company is progressing with JW-700, a formulation targeted at treating hair loss, and JW-500, designed to support women's sexual wellness, indicating a commitment to broader personal care markets. Completing its diverse product range is NoStingz, an innovative sunscreen offering specialized protection against jellyfish stings, catering to niche outdoor and recreational markets. Safety Shot, Inc. employs a multi-channel distribution strategy to reach its customer base, utilizing wholesale distributors, conventional retail outlets, and direct-to-consumer e-commerce platforms to maximize market penetration and accessibility for its proprietary products.

What Products and Services Does SHOT Offer?

• Researches and develops proprietary intellectual property for consumer products.
• Commercializes over-the-counter wellness and functional beverages.
• Produces the Safety Shot Beverage, designed to expedite blood alcohol content reduction.
• Develops Photocil for treating dermatological conditions like psoriasis and vitiligo.
• Works on JW-700, a therapeutic solution aimed at addressing hair loss.
• Formulates JW-500 to support women's sexual wellness.
• Offers NoStingz, an innovative sunscreen providing protection against jellyfish stings.
• Distributes products through wholesale channels, conventional retail outlets, and direct-to-consumer e-commerce platforms.

How Does SHOT Make Money?

• Generates revenue through the direct sale of its proprietary functional beverages and over-the-counter wellness products.
• Utilizes wholesale distributors to place products in conventional retail outlets, expanding market reach.
• Engages in direct-to-consumer sales via e-commerce platforms, offering accessibility and direct customer engagement.
• Focuses on the commercialization of its developed intellectual property across multiple health and wellness categories.

What Industry Does SHOT Operate In?

Safety Shot, Inc. operates within the expansive and evolving consumer defensive sector, specifically carving a niche in the Beverages - Non-Alcoholic industry, with a strong emphasis on functional wellness products. The broader functional beverage market is experiencing robust growth, driven by increasing consumer demand for health-conscious and performance-enhancing drinks. Safety Shot's flagship product, designed for blood alcohol reduction, positions it in a nascent but potentially high-growth segment within this market. The company also extends into the competitive over-the-counter (OTC) therapeutic market with its pipeline products addressing dermatological conditions, hair loss, and women's sexual wellness. This dual focus places Safety Shot, Inc. at the intersection of several growing wellness trends, but also exposes it to intense competition from established beverage giants and pharmaceutical companies. Its ability to differentiate through proprietary intellectual property and effective marketing will be crucial in securing market share amidst these trends.

Who Are SHOT's Key Customers?

• Consumers seeking functional beverages for post-alcohol recovery and general wellness.
• Individuals with dermatological conditions such as psoriasis and vitiligo seeking therapeutic solutions.
• Consumers experiencing hair loss looking for treatment options.
• Women interested in products supporting sexual wellness.
• Outdoor enthusiasts and travelers requiring specialized sun protection against marine hazards like jellyfish.

Company Profile

Safety Shot, Inc. operates in the Beverages - Non-Alcoholic industry within the Consumer Defensive sector. It is headquartered in Jupiter, US. The company is led by CEO Jarrett A. Boon. SHOT has traded publicly since 2020.

Safety Shot, Inc. Financial Trajectory

Safety Shot, Inc. (SHOT) reported $786K in revenue for Q1 2026, based on the latest filing compared to the prior quarter. The company recorded a net loss of $1.8M, with diluted EPS of $-0.23. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Consumer Defensive. Across the four most recent quarters, SHOT averaged $-2.75 in diluted EPS.

How Safety Shot, Inc. Is Valued

Safety Shot, Inc. carries a market capitalization of $47.41M, placing it in the micro-cap category. Relative to its peer group, SHOT's quantitative score of 45/100 is below the peer average of 57/100.

F-Score 3/9Financial Health

Safety Shot, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.

Net buyingInsider Activity

The most recent 9 insider filings for Safety Shot, Inc. break down as 4 sales and 5 purchases. On net that is roughly 2.9M shares acquired (about $1.1B) — insiders putting money in tends to read as conviction.

SHOT Financials

SHOT Latest News

No recent news available for SHOT.

SHOT Analyst Consensus

SHOT MoonshotScore

SHOT Consumer Defensive Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources